FGF19 and diabetes mellitus: FXR stimulates the secretion of fibroblast growth factor 19 into the portal circulation and activates its fibroblast growth factor 4 liver receptor, leading to decreased gluconeogenesis glycemia and improved insulin sensitivity and glucose and lipid metabolism in diabetes [27, 28].